Primary |
Drug Use For Unknown Indication |
39.1% |
Drug Dependence |
16.4% |
Product Used For Unknown Indication |
13.0% |
Foetal Exposure During Pregnancy |
9.7% |
Pain |
5.5% |
Anxiety |
1.7% |
Drug Withdrawal Maintenance Therapy |
1.7% |
Mania |
1.7% |
Drug Abuse |
1.3% |
Drug Withdrawal Syndrome |
1.3% |
Psoriasis |
1.3% |
Alcohol Withdrawal Syndrome |
0.8% |
Arthralgia |
0.8% |
Arthritis |
0.8% |
Bladder Pain |
0.8% |
Depression |
0.8% |
Drug Therapy |
0.8% |
Muscle Spasms |
0.8% |
Pain Management |
0.8% |
Sleep Disorder |
0.8% |
|
Toxicity To Various Agents |
23.8% |
Substance Abuse |
11.0% |
Accidental Overdose |
8.3% |
Overdose |
7.7% |
Product Quality Issue |
7.7% |
Drug Toxicity |
6.1% |
Pneumonia |
5.0% |
Vomiting |
5.0% |
Foetal Non-stress Test Abnormal |
3.9% |
Nausea |
3.3% |
Maternal Drugs Affecting Foetus |
2.8% |
Withdrawal Syndrome |
2.8% |
Product Taste Abnormal |
2.2% |
Wrong Technique In Drug Usage Process |
2.2% |
Completed Suicide |
1.7% |
Death |
1.7% |
Suicide Attempt |
1.7% |
Adverse Reaction |
1.1% |
Blood Pressure Increased |
1.1% |
Drowning |
1.1% |
|
Secondary |
Product Used For Unknown Indication |
26.5% |
Back Pain |
10.3% |
Osteoarthritis |
10.3% |
Drug Dependence |
9.4% |
Pain |
9.0% |
Drug Use For Unknown Indication |
8.1% |
Thrombosis Prophylaxis |
6.0% |
Ankylosing Spondylitis |
3.4% |
Anaemia Haemolytic Autoimmune |
1.7% |
Analgesic Therapy |
1.7% |
Intervertebral Disc Protrusion |
1.7% |
Musculoskeletal Pain |
1.7% |
Sciatica |
1.7% |
Adverse Reaction |
1.3% |
Cancer Pain |
1.3% |
Drug Abuse |
1.3% |
Pneumonia |
1.3% |
Psoriasis |
1.3% |
Sedative Therapy |
1.3% |
Alcohol Withdrawal Syndrome |
0.9% |
|
Withdrawal Syndrome |
13.2% |
Electrocardiogram Qt Prolonged |
11.3% |
Myocardial Ischaemia |
7.5% |
Deafness Bilateral |
5.7% |
Mechanical Urticaria |
5.7% |
Myocardial Infarction |
5.7% |
Pain |
5.7% |
Weight Gain Poor |
5.7% |
Deafness |
3.8% |
Drug Withdrawal Syndrome |
3.8% |
Gastric Ulcer Perforation |
3.8% |
Overdose |
3.8% |
Premature Rupture Of Membranes |
3.8% |
Speech Disorder |
3.8% |
Unevaluable Event |
3.8% |
Vomiting |
3.8% |
Wrong Technique In Drug Usage Process |
3.8% |
Accidental Overdose |
1.9% |
Blood Creatine Phosphokinase Increased |
1.9% |
Cerebrovascular Spasm |
1.9% |
|
Concomitant |
Product Used For Unknown Indication |
31.9% |
Acute Myeloid Leukaemia |
12.6% |
Drug Use For Unknown Indication |
12.6% |
Postoperative Care |
8.4% |
Depression |
3.8% |
Neuralgia |
3.8% |
Plasmacytoma |
3.8% |
Crohn's Disease |
3.4% |
Gastrointestinal Carcinoma |
3.4% |
Procedural Pain |
2.5% |
Bladder Cancer |
1.7% |
Prophylaxis |
1.7% |
Sedation |
1.7% |
Bipolar Disorder |
1.3% |
Bone Marrow Transplant |
1.3% |
Colorectal Cancer Metastatic |
1.3% |
Drug Dependence |
1.3% |
Epidural Anaesthesia |
1.3% |
Pain |
1.3% |
Pneumonia Bacterial |
1.3% |
|
Malignant Neoplasm Progression |
9.8% |
Post Procedural Bile Leak |
9.8% |
Vomiting |
9.8% |
Pyrexia |
7.3% |
Thrombocytopenia |
7.3% |
Urine Output Decreased |
7.3% |
Cardiac Tamponade |
4.9% |
Hallucinations, Mixed |
4.9% |
Unevaluable Event |
4.9% |
Vaginal Haemorrhage |
4.9% |
Viral Infection |
4.9% |
Visual Field Tests Abnormal |
4.9% |
Agranulocytosis |
2.4% |
Cholestatic Liver Injury |
2.4% |
Compartment Syndrome |
2.4% |
Condition Aggravated |
2.4% |
Coordination Abnormal |
2.4% |
Death |
2.4% |
Drug Screen False Positive |
2.4% |
Hair Growth Abnormal |
2.4% |
|
Interacting |
Depression |
22.2% |
Premedication |
22.2% |
Abdominal Pain |
11.1% |
Epidural Anaesthesia |
11.1% |
Induction And Maintenance Of Anaesthesia |
11.1% |
Induction Of Anaesthesia |
11.1% |
Nausea |
11.1% |
|
Overdose |
33.3% |
Oxygen Saturation Decreased |
33.3% |
Potentiating Drug Interaction |
33.3% |
|